Publications

In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

 22
In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis

Tags:

Previous Article

Molecular mechanisms of endometriosis and comorbidities

Next Article

Predicting if multiple sclerosis medication will be effective for patients

Related Posts

Strategies to boost antibody selectivity in oncology

Strategies to boost antibody selectivity in oncology

 74

Distinct roles of monkey OFC-subcortical pathways in adaptive behavior

Distinct roles of monkey OFC-subcortical pathways in ad...

 57

Kinesin-like motor protein KIF23 maintains neural stem and progenitor cell pools in the developing cortex

Kinesin-like motor protein KIF23 maintains neural stem ...

 55